The reduction in anemia prevalence at high altitudes is most likely due to the effects of hypoxia on stimulating the production and release of erythropoietin (EPO), the most potent stimulator of erythropoiesis, in renal [52] and extra-renal tissues [53–62]. The gene discussed is EPO; the disease is anemia.